4//SEC Filing
Syros Pharmaceuticals, Inc. 4
Accession 0001179110-17-002280
CIK 0001556263operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:17 PM ET
Size
5.5 KB
Accession
0001179110-17-002280
Insider Transaction Report
Form 4
Kuvalanka Kyle D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-10+78,000→ 78,000 totalExercise: $10.90Exp: 2027-02-09→ Common Stock (78,000 underlying)
Footnotes (1)
- [F1]This option becomes exercisable as to 25% of the shares underlying the award on February 10, 2018, with the remainder vesting in equal monthly installments of 2.0833% of the shares underlying the award at the end of each successive month thereafter.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001556263
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:17 PM ET
- Size
- 5.5 KB